Fennec Pharmaceuticals Inc. (FENC)

NCM – Цена в реальном времени. Валюта: USD

11.83

-0.95 (-7.43%)

При закрытии: Aug 12, 2026, 4:00 PM EDT

12.06

+0.23 (1.94%)

После закрытия: Aug 12, 2026, 5:09 PM EDT

12.08.2026

Can Adherex Technologies (FENC) Climb 26.53% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for Adherex Technologies (FENC) points to a 26.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

11.08.2026

Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call Transcript

11.08.2026

Adherex Technologies Q2 Earnings Call Highlights

Adherex Technologies NASDAQ: FENC, operating as Fennec Pharmaceuticals, reported second-quarter 2026 net product sales of $17.1 million, up approximately 78% from $9.7 million in the prior-year period, as demand for its PEDMARK therapy continued to rise.

11.08.2026

Adherex Technologies Inc. (FENC) Beats Q2 Earnings and Revenue Estimates

Adherex Technologies Inc. (FENC) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to a loss of $0.11 per share a year ago.

05.08.2026

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its second quarter 2026 financial results before the opening of the U.S. financial markets on Tuesday, August 11, 2026. Management will host a conference call and webcast that day to discuss the Company's financial and business results.

Видео

No Data

There is no data to display

Fennec Pharmaceuticals Inc. (FENC)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Fennec Pharmaceuticals Inc. (FENC)

Can Adherex Technologies (FENC) Climb 26.53% to Reach the Level Wall Street Analysts Expect?

Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call Transcript

Adherex Technologies Q2 Earnings Call Highlights

Adherex Technologies Inc. (FENC) Beats Q2 Earnings and Revenue Estimates

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

Видео

No Data

Can Adherex Technologies (FENC) Climb 26.53% to Reach the Level Wall Street Analysts Expect?

Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call Transcript

Adherex Technologies Q2 Earnings Call Highlights

Adherex Technologies Inc. (FENC) Beats Q2 Earnings and Revenue Estimates

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

Видео

No Data

Search stocks

Fennec Pharmaceuticals Inc. (FENC)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Fennec Pharmaceuticals Inc. (FENC)

Can Adherex Technologies (FENC) Climb 26.53% to Reach the Level Wall Street Analysts Expect?

Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call Transcript

Adherex Technologies Q2 Earnings Call Highlights

Adherex Technologies Inc. (FENC) Beats Q2 Earnings and Revenue Estimates

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

Видео

No Data

Can Adherex Technologies (FENC) Climb 26.53% to Reach the Level Wall Street Analysts Expect?

Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call Transcript

Adherex Technologies Q2 Earnings Call Highlights

Adherex Technologies Inc. (FENC) Beats Q2 Earnings and Revenue Estimates

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

Видео

No Data